Literature DB >> 10507624

Effects of inhaled nitric oxide on pulmonary hemodynamics in a porcine model of endotoxin shock.

B Lambermont1, V D'Orio, P Kolh, P Gérard, R Marcelle.   

Abstract

OBJECTIVE: To evaluate the effects of inhaled nitric oxide (NO) on pulmonary circulation in a porcine endotoxin shock model.
DESIGN: Prospective, randomized trial.
SETTING: Laboratory at a large university medical center.
SUBJECTS: Twelve pathogen-free pigs weighing 15 to 31 kg.
INTERVENTIONS: After surgical preparation, all pigs received a 0.5 mg/kg endotoxin infusion over 30 mins. One hour after the start of endotoxin, NO inhalation (40 ppm) was initiated in six pigs, whereas the six remaining pigs served to control the progression of shock in this model. Consecutive changes in systemic and pulmonary hemodynamics, including characteristic resistance, vascular compliance, peripheral vascular resistance, and inductance, were continuously assessed during the experimental protocol using a four-element Windkessel model of the pulmonary circulation.
MEASUREMENTS AND MAIN RESULTS: Endotoxin insult resulted in a biphasic pulmonary artery pressure increase from 14 +/- 2 to 32 +/- 4 mm Hg. Inhaled NO reversed the resistance to blood flow in small pulmonary arteries from 596 +/- 69 to 424 +/- 36 dyne-sec/ cm5. In contrast, the vascular capacitance of the entire pulmonary circuit, which decreased from 2.4 +/- 0.2 to 0.8 +/- 0.1 mL/mm Hg throughout endotoxin challenge, remained insensitive to NO administration.
CONCLUSION: In endotoxin-induced pulmonary hypertension, inhaled NO may function as a modulator of distal pulmonary arterial tone but fails to act as a regulator of larger capacitance pulmonary vessels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507624     DOI: 10.1097/00003246-199909000-00039

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  1 in total

1.  Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs.

Authors:  Kristofer F Nilsson; Waldemar Goździk; Claes Frostell; Stanisław Zieliński; Marzena Zielińska; Kornel Ratajczak; Piotr Skrzypczak; Sylwia Rodziewicz; Johanna Albert; Lars E Gustafsson
Journal:  Drug Des Devel Ther       Date:  2018-03-29       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.